Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy

被引:58
作者
Stone, VE
Mansourati, FF
Poses, RM
Mayer, KH
机构
[1] Brown Univ, Mem Hosp Rhode Isl, Dept Med, Div Gen Internal Med, Providence, RI 02912 USA
[2] Brown Univ, Mem Hosp Rhode Isl, Dept Med, Div Infect Dis, Providence, RI 02912 USA
关键词
HIV/AIDS; physician specialty; antiretroviral therapy;
D O I
10.1046/j.1525-1497.2001.016006360.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Controversy exists regarding who should provide care for those with HIV/AIDS. While previous studies have found an association between physician HIV experience and patient outcomes, less is known about the relationship of physician specialty to HIV/AIDS outcomes or quality of care. Objective: To examine the relationship between choice of appropriate antiretroviral therapy (ART) to physician specialty and HIV/AIDS experience. Design: Self-administered physician survey. Participants: Random sample of 2,478 internal medicine (IM) and infectious disease (ID) physicians. Measurements: Choice of guideline-recommended ART. Results: Two patients with HIV disease, differing only by CD4+ count and HIV RNA load, were presented, Respondents were asked whether ART was indicated, and if so, what ART regimen they would choose. Respondents' ART choices were categorized as "recommended" or not by Department of Health and Human Services guidelines. Respondents' HIV/AIDS experience was categorized as moderate to high (MOD/HI) or none to low (NO/LO). For Case 1, 72.9% of responding physicians chose recommended ART. Recommended ART was more Likely (P<.01) to be chosen by ID physicians (88.2%) than by IM physicians (57.1%). Physicians with MOD/HI experience were also more likely (P <.01) to choose recommended ART than those with NO/LO experience. Finally, choice of ART was examined using logistic regression: specialty and HIV experience were found to be independent predictors of choosing recommended ART (for ID physicians, odds ratio [OR], 4.66; 95% confidence interval [95% CI], 3.15 to 6.90; and for MOD/HI experience, OR, 2.05; 95% CI, 1.33 to 3.16). Results for Case 2 were similar. When the analysis was repeated excluding physicians who indicated they would refer the HIV "patient," specialty and HIV experience were not significant predictors of choosing recommended ART. Conclusions: Guideline-recommended ART appears to be less likely to be chosen by generalists and physicians with less HIV/AIDS experience, although many of these physicians report they would refer these patients in clinical practice. These results lend support to current recommendations for routine expert consultant input in the management of those with HIV/AIDS.
引用
收藏
页码:360 / 368
页数:9
相关论文
共 37 条
[1]   KNOWLEDGE AND PRACTICES OF GENERALIST AND SPECIALIST PHYSICIANS REGARDING DRUG-THERAPY FOR ACUTE MYOCARDIAL-INFARCTION [J].
AYANIAN, JZ ;
HAUPTMAN, PJ ;
GUADAGNOLI, E ;
ANTMAN, EM ;
PASHOS, CL ;
MCNEIL, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (17) :1136-1142
[2]   Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians [J].
Ayanian, JZ ;
Guadagnoli, E ;
McNeil, BJ ;
Cleary, PD .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (22) :2570-2576
[3]   The relation between physician experience and patterns of care for patients with AIDS-related Pneumocystis carinii pneumonia -: Results from a survey of 1,500 physicians in the United States [J].
Bach, PB ;
Calhoun, EA ;
Bennett, CL .
CHEST, 1999, 115 (06) :1563-1569
[4]   Clinical experience and choice of drug therapy for human immunodeficiency virus disease [J].
Brosgart, CL ;
Mitchell, TF ;
Coleman, RL ;
Dyner, T ;
Stephenson, KE ;
Abrams, DI .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (01) :14-22
[5]  
*BUR HLTH PROF, 1996, 7 REP PRES C STAT HL
[6]  
CAMERON B, 1996, 3 C RETR OPP INF WAS
[7]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[8]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[9]  
*CDCP, 1994, JAMA-J AM MED ASSOC, V27, P261
[10]  
*CDCP, 2000, HIV AIDS SURV REP 19, V9, P5